MIR1246 is a microRNA that has been studied in the context of cancer, where its levels in serum and urine have been analyzed for potential correlations with various aspects of cancer progression [PMC7250935]. Despite the investigation, no significant correlations were found between MIR1246 levels and the extent of tumor invasion, the presence of lymph node metastasis, distant metastasis, or the overall stage of cancer [PMC7250935]. Additionally, MIR1246 has been identified to have a molecular target in cells; it is capable of binding to early B cytokine 1 (EBF1) at its 3′ untranslated region (3′UTR), suggesting a role in post-transcriptional regulation [PMC8258133]. This interaction between MIR1246 and EBF1 indicates that while MIR1246 may not be directly correlated with cancer progression markers such as invasion or metastasis, it could still play a role in cellular processes through its influence on EBF1 [PMC8258133].
-- -au ugA ------- AG agu ugu ccu AUGGAUU UUUGG CAGG g ||| ||| ||||||| ||||| |||| acg gga uaccuaa aaacc gucc g ua auc --- cuaaagg ca aca
Disease | Description | Category | PubMed ID |
---|
Accession | MIMAT0005898 |
Description | Homo sapiens hsa-miR-1246 mature miRNA |
Sequence | 11 - AAUGGAUUUUUGGAGCAGG - 29 |
Evidence |
experimental
Illumina [1] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() ![]() |
|